Celestica Inc. (NYSE:CLS) Insider Sells $914,137.92 in Stock

Celestica Inc. (NYSE:CLSGet Free Report) (TSE:CLS) insider Alok K. Agrawal sold 6,826 shares of the business’s stock in a transaction dated Wednesday, February 5th. The stock was sold at an average price of $133.92, for a total value of $914,137.92. Following the sale, the insider now owns 9,224 shares in the company, valued at approximately $1,235,278.08. This trade represents a 42.53 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

Celestica Price Performance

Celestica stock opened at $129.74 on Friday. The stock has a market capitalization of $15.10 billion, a price-to-earnings ratio of 34.69 and a beta of 2.27. Celestica Inc. has a 52-week low of $36.00 and a 52-week high of $144.27. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.87 and a current ratio of 1.47. The stock’s 50 day moving average price is $102.31 and its two-hundred day moving average price is $74.25.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the stock. PFG Advisors increased its stake in Celestica by 4.6% in the fourth quarter. PFG Advisors now owns 10,162 shares of the technology company’s stock valued at $938,000 after purchasing an additional 450 shares in the last quarter. Wealth High Governance Capital Ltda bought a new stake in Celestica in the 4th quarter valued at about $9,162,000. Moors & Cabot Inc. bought a new stake in Celestica in the 4th quarter valued at about $258,000. Prosperity Wealth Management Inc. acquired a new position in Celestica during the 4th quarter worth approximately $262,000. Finally, Independent Advisor Alliance boosted its holdings in Celestica by 0.3% in the fourth quarter. Independent Advisor Alliance now owns 29,588 shares of the technology company’s stock worth $2,731,000 after acquiring an additional 79 shares in the last quarter. 67.38% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the stock. Cibc World Mkts raised shares of Celestica from a “hold” rating to a “strong-buy” rating in a report on Friday, January 31st. Stifel Nicolaus assumed coverage on shares of Celestica in a research note on Tuesday. They issued a “buy” rating and a $140.00 price objective on the stock. UBS Group initiated coverage on Celestica in a research report on Friday, November 22nd. They set a “neutral” rating and a $95.00 target price for the company. Barclays upped their price target on Celestica from $91.00 to $139.00 and gave the company an “overweight” rating in a research report on Thursday, January 30th. Finally, TD Cowen raised their price objective on Celestica from $68.00 to $70.00 and gave the stock a “buy” rating in a research report on Thursday, October 24th. Two investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Celestica currently has an average rating of “Moderate Buy” and a consensus price target of $103.27.

Check Out Our Latest Report on CLS

About Celestica

(Get Free Report)

Celestica Inc provides supply chain solutions in North America, Europe, and Asia. It operates through two segments: Advanced Technology Solutions, and Connectivity & Cloud Solutions. The company offers a range of product manufacturing and related supply chain services, including design and development, new product introduction, engineering services, component sourcing, electronics manufacturing and assembly, testing, complex mechanical assembly, systems integration, precision machining, order fulfillment, logistics, asset management, product licensing, and after-market repair and return services.

Recommended Stories

Insider Buying and Selling by Quarter for Celestica (NYSE:CLS)

Receive News & Ratings for Celestica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celestica and related companies with MarketBeat.com's FREE daily email newsletter.